Patricia Barditch‐Crovo

3.8k total citations · 1 hit paper
27 papers, 3.0k citations indexed

About

Patricia Barditch‐Crovo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Patricia Barditch‐Crovo has authored 27 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Patricia Barditch‐Crovo's work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (8 papers). Patricia Barditch‐Crovo is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (8 papers). Patricia Barditch‐Crovo collaborates with scholars based in United States, Switzerland and Germany. Patricia Barditch‐Crovo's co-authors include Robert F. Siliciano, Joseph B. Margolick, Karen Chadwick, Monika Hermankova, Harry L. Taylor, Tae‐Wook Chun, Diana Finzi, Martha A. Zeiger, Ronald Brookmeyer and Lucy M. Carruth and has published in prestigious journals such as Nature, Annals of Internal Medicine and The Journal of Infectious Diseases.

In The Last Decade

Patricia Barditch‐Crovo

27 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1997 1.6k citations Tae‐Wook Chun, Lucy M. Carruth et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia Barditch‐Crovo United States	17	2.0k	1.7k	691	635	320	27	3.0k
Miklos Salgo United States	22	1.9k 1.0×	2.1k 1.2×	415 0.6×	539 0.8×	469 1.5×	53	3.2k
Ven Natarajan United States	26	1.7k 0.8×	1.2k 0.7×	892 1.3×	531 0.8×	436 1.4×	56	2.6k
William Spreen United States	30	1.8k 0.9×	2.4k 1.4×	381 0.6×	693 1.1×	287 0.9×	80	3.6k
John Spritzler United States	29	1.8k 0.9×	1.4k 0.8×	925 1.3×	911 1.4×	287 0.9×	55	3.2k
M. Dietrich Germany	24	963 0.5×	1.1k 0.7×	645 0.9×	779 1.2×	152 0.5×	70	2.7k
Corey Moore Australia	12	1.4k 0.7×	1.2k 0.7×	772 1.1×	424 0.7×	325 1.0×	19	2.9k
Douglas L. Mayers United States	30	2.5k 1.3×	2.9k 1.6×	311 0.5×	802 1.3×	335 1.0×	90	3.9k
Sylvie Abel Martinique	25	794 0.4×	1.1k 0.6×	220 0.3×	473 0.7×	196 0.6×	62	2.0k
Kirk D. Miller United States	22	1.3k 0.6×	1.3k 0.7×	313 0.5×	491 0.8×	192 0.6×	34	2.7k
Cassy Workman Australia	16	1.3k 0.6×	1.2k 0.7×	514 0.7×	359 0.6×	217 0.7×	30	2.7k

Countries citing papers authored by Patricia Barditch‐Crovo

Since Specialization

Citations

This map shows the geographic impact of Patricia Barditch‐Crovo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Barditch‐Crovo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Barditch‐Crovo more than expected).

Fields of papers citing papers by Patricia Barditch‐Crovo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Barditch‐Crovo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Barditch‐Crovo. The network helps show where Patricia Barditch‐Crovo may publish in the future.

Co-authorship network of co-authors of Patricia Barditch‐Crovo

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Barditch‐Crovo. A scholar is included among the top collaborators of Patricia Barditch‐Crovo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Barditch‐Crovo. Patricia Barditch‐Crovo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hays, Allison G., Michael Schär, Patricia Barditch‐Crovo, et al.. (2021). A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV. AIDS. 35(7). 1041–1050. 17 indexed citations

Iantorno, Micaela, Michael Schär, Todd T. Brown, et al.. (2018). Regional coronary endothelial dysfunction is related to the degree of local epicardial fat in people with HIV. Atherosclerosis. 278. 7–14. 19 indexed citations

Iantorno, Micaela, Michael Schär, Todd T. Brown, et al.. (2017). Coronary artery endothelial dysfunction is present in HIV-positive individuals without significant coronary artery disease. AIDS. 31(9). 1281–1289. 33 indexed citations

Lucas, Gregory M., Amina Chaudhry, Jeffrey H. Hsu, et al.. (2010). Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program. Annals of Internal Medicine. 5 indexed citations

Han, Yefei, Jun Lai, Patricia Barditch‐Crovo, et al.. (2008). The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors. AIDS. 22(4). 541–544. 47 indexed citations

Pham, Paul A., Charles Flexner, Teresa L. Parsons, et al.. (2007). Beneficial Pharmacokinetic Interaction Between Atazanavir and Lopinavir/Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 201–205. 10 indexed citations

Pham, Paul A., Craig W. Hendrix, Patricia Barditch‐Crovo, et al.. (2007). Amprenavir and Lopinavir Pharmacokinetics following Coadministration of Amprenavir or Fosamprenavir with Lopinavir/Ritonavir, with or without Efavirenz. Antiviral Therapy. 12(6). 963–970. 6 indexed citations

Deeks, Steven G., Patricia Barditch‐Crovo, Ann C. Collier, et al.. (2001). Hydroxyurea Does Not Enhance the Anti-HIV Activity of Low-Dose Tenofovir Disoproxil Fumarate. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(4). 336–339. 5 indexed citations

Witter, Frank R., et al.. (1999). Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives. International Journal of Gynecology & Obstetrics. 65(2). 165–170. 27 indexed citations

10.

Barditch‐Crovo, Patricia, Carol Braun Trapnell, Ene Ette, et al.. (1999). The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clinical Pharmacology & Therapeutics. 65(4). 428–438. 87 indexed citations

11.

Brown, Henry G., et al.. (1999). Intracranial leiomyosarcoma in a patient with AIDS. Neuroradiology. 41(1). 35–39. 45 indexed citations

12.

Shapiro, Theresa A., Channa D Ranasinha, Nirbhay Kumar, & Patricia Barditch‐Crovo. (1999). Prophylactic activity of atovaquone against Plasmodium falciparum in humans.. American Journal of Tropical Medicine and Hygiene. 60(5). 831–836. 60 indexed citations

13.

Barditch‐Crovo, Patricia, Dennis A. Noe, Gail Skowron, et al.. (1998). A Phase I/II Evaluation of Oral L‐2‐Oxothiazolidine‐4‐Carboxylic Acid in Asymptomatic Patients Infected with Human Immunodeficiency Virus. The Journal of Clinical Pharmacology. 38(4). 357–363. 16 indexed citations

14.

Barditch‐Crovo, Patricia, Brent G. Petty, John G. Gambertoglio, et al.. (1998). The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet. Antiviral Research. 38(3). 209–212. 2 indexed citations

15.

Barditch‐Crovo, Patricia, et al.. (1997). Anti‐Human Immunodeficiency Virus (HIV) Activity, Safety, and Pharmacokinetics of Adefovir Dipivoxil (9‐[2‐(bis‐pivaloyloxymethyl)‐phosphonylmethoxyethyl]adenine) in HIV‐Infected Patients. The Journal of Infectious Diseases. 176(2). 406–413. 86 indexed citations

16.

Chun, Tae‐Wook, Lucy M. Carruth, Diana Finzi, et al.. (1997). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387(6629). 183–188. 1611 indexed citations breakdown →

17.

Barditch‐Crovo, Patricia, et al.. (1997). Quantitation of vaginally administered nonoxynol-9 in premenopausal women. Contraception. 55(4). 261–263. 7 indexed citations

18.

Nichols, James H., et al.. (1996). Determination of the spermicide nonoxynol-9 in vaginal lavage by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 677(1). 204–208. 4 indexed citations

19.

Cundy, K C, Patricia Barditch‐Crovo, Robert Walker, et al.. (1995). Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrobial Agents and Chemotherapy. 39(11). 2401–2405. 109 indexed citations

20.

Flexner, Charles, William G. Powderly, Frederick P. Duncanson, et al.. (1994). Relationship Between Plasma Concentrations Of 3'-Deoxy-3'-Fluorothymidine (Alovudine) And Antiretroviral Activity In Two Concentration-Controlled Trials. The Journal of Infectious Diseases. 170(6). 1394–1403. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact